Ely A. Wolin: Top 3 Differentials in Nuclear Medicine: A Case Review Luigi Mansi Book Review 31 August 2019 Pages: 1 - 1
Duccio Volterrani, Paola Anna Erba, Ignasi Carrió, H. William Strauss, Giuliano Mariani. Nuclear Medicine Textbook Methodology and Clinical Application, 2 Volumes. Springer Nature Switzerland AG 2019, ISBN 978-3-319-95563-6 Luigi Mansi Book Review 16 October 2019 Pages: 2 - 3
Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors Laure MichaudB. J. BeattieR. Blasberg Correction Open access 07 September 2019 Pages: 4 - 4
Comment on: “the FDG PET/CT score” for the diagnosis of malignant pleural effusion Dharmender Malik Letter to the Editor 04 September 2019 Pages: 5 - 6
Fitting of late dynamic [18F]MK6240 PET scans for in vivo tau quantification Eric LaffonSébastien BujRoger Marthan Letter to the Editor 16 October 2019 Pages: 7 - 8
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients Sofia VazBoris HadaschikDurval Costa Editorial 25 October 2019 Pages: 9 - 15
Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer Gary J. R. Cook Editorial 17 October 2019 Pages: 16 - 17
An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders Abass AlaviSøren HessPoul Flemming Høilund-Carlsen Editorial 04 September 2019 Pages: 18 - 27
Good clinical practice recommendations for the use of PET/CT in oncology Pierre-Yves SalaünRonan AbgralFlorent Cachin Guidelines 21 October 2019 Pages: 28 - 50
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations Marius E. MayerhoeferHelmut ProschAlexander R. Haug Original Article Open access 13 August 2019 Pages: 51 - 60
EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma Luca GiovanellaGiorgio TregliaMarkus Luster Guidelines 04 September 2019 Pages: 61 - 77
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade Frederik A. VerburgGlenn FluxMarkus Luster Review Article Open access 15 October 2019 Pages: 78 - 83
A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma Chun-Ta LiaoChia-Hsun HsiehTzu-Chen Yen Original Article 06 August 2019 Pages: 84 - 93
Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma Chih-Hua YehSheng-Chieh ChanShu-Hang Ng Original Article 12 October 2019 Pages: 94 - 104
Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer Barbara J. AmorimVinay PrabhuOnofrio A. Catalano Original Article 06 September 2019 Pages: 105 - 114
Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements Lucia BarattoHeying DuanAndrei Iagaru Original Article 02 September 2019 Pages: 115 - 122
First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer Jens KurthBernd Joachim KrauseMartin Heuschkel Original Article 03 September 2019 Pages: 123 - 135
Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer Francesco CeciLorenzo BianchiStefano Fanti Original Article 06 September 2019 Pages: 136 - 146
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer Daniela A. FerraroUrs J. MuehlematterIrene A. Burger Original Article 14 September 2019 Pages: 147 - 159
Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions Ian AlbertsChristos SachpekidisAli Afshar-Oromieh Original Article 18 October 2019 Pages: 160 - 167
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer Wojciech CytawaAnna Katharina SeitzConstantin Lapa Original Article 16 September 2019 Pages: 168 - 177
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab Ilhan LimMaria Liza LindenbergAndrea B. Apolo Original Article Open access 14 September 2019 Pages: 178 - 184
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer Francesco PasqualettiMarco PanichiPaola Anna Erba Original Article Open access 16 October 2019 Pages: 185 - 191
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice Sabina DizdarevicRalph McCreadySobhan Vinjamuri Review Article 30 August 2019 Pages: 192 - 217
An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT Mine ArazCigdem SoydalTaner Demirer Image of the Month 25 July 2019 Pages: 218 - 219
18F-F13640 PET imaging of functional receptors in humans Matthieu ColomNicolas CostesLuc Zimmer Image of the Month 14 August 2019 Pages: 220 - 221
18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease Paula Fernández-RodríguezRosa Fernández LópezJosé Manuel Jiménez-Hoyuela García Image of the Month 07 September 2019 Pages: 222 - 223